Updated on 4 August 2026
MYRTO AI & KAPA3: Patient-Centred Digital Support, Advocacy & Innovation in Cancer Care
Healthcare IT & Patient Advocate at Cancer Guidance Center - KAPA3
Alexandroupolis, Greece
About
KAPA3 (Cancer Guidance Center) is a Greek non-profit organisation dedicated to improving the cancer journey for patients, caregivers and families through integrated, person-centred support. Operating at the intersection of social care, patient empowerment and digital health, KAPA3 addresses critical barriers to equitable and timely cancer care.
Through its Mobile Information and Support Units and local guidance pathways, KAPA3 provides patients and caregivers with a consistent point of contact throughout the cancer journey. A core strength of KAPA3 is its ability to translate complex medical, administrative, legal and technological information into understandable and patient-friendly content.
KAPA3 brings strong experience in:
-
Patient navigation and support across the care pathway
-
Psychosocial and caregiver support
-
Patient rights, access and health equity
-
Community-based interventions and real-world engagement
-
Collaboration with healthcare providers, hospitals, universities, public authorities and civil society.
KAPA3 develops innovative digital solutions such as MYRTO, an AI-enabled digital social assistant designed to:
-
Support patients and caregivers with personalized, accessible guidance
-
Improve access to reliable information and available services
-
Facilitate care navigation and continuity of support
-
Empower patients in managing their care journey.
KAPA3 is particularly aligned with:
-
Digital health and AI for patient support services
-
Virtual Human Twins (from a patient integration & usability perspective)
-
AI/AGI applications in healthcare (non-clinical layer: access, navigation, empowerment)
-
Cancer Mission priorities (quality of life, survivorship, inequalities).
KAPA3 can contribute as:
-
Patient advocacy and engagement partner
-
Pilot preparation and implementation
-
Support for informed-consent support and safeguarding
-
User testing and validation of integrated support pathways
-
End-user validation & co-creation
-
Dissemination, communication and stakeholder engagement partner
-
Provider of real-world patient and caregiver feedback and needs assessment for ethical, inclusive and human-centric AI approaches
-
Evaluator of how AI-generated information is understood by patients and caregivers.
KAPA3 is interested in:
-
Joining consortia as a patient-centered impact and engagement partner
-
Supporting projects in user validation, co-design and dissemination
-
Ensuring alignment with patient needs and real-world conditions
KAPA3 ensures:
-
Strong integration of patient perspective
-
Increased societal relevance and adoption
-
Reduction of inequalities in access to cancer support services
-
Human-centric and ethical implementation of digital health solutions
Topic
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
HORIZON-MISS-2027-02-CANCER-04 – Greek ecosystem partner
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
George Dimitriou
Cluster Manager at HELLENIC DIGITAL HEALTH CLUSTER
Athens, Greece
Project cooperation
Lidia Dyndor
Senior Project Specialist at Maria Skłodowska-Curie National Research Institute of Oncology (MSCI)
Warsaw, Poland
Project cooperation
SIGORIA Expertise for Horizon Europe Calls: DISEASE-01, CANCER-02 & TOOL-04
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Sebastian Kawczyński
CEO at SIGORIA SECURITY SOLUTIONS
Łódź, Poland